PCSK9

Clinical trials for PCSK9 explained in plain language.

Never miss a new study

Get alerted when new PCSK9 trials appear

Sign up with your email to follow new studies for PCSK9, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to slash heart attacks in patients with dangerous plaques

Disease control Recruiting now

This study tests whether adding a PCSK9 inhibitor (a powerful cholesterol-lowering drug) to standard treatment can prevent major heart problems like heart attacks, strokes, or death in people with high-risk coronary plaques seen on CT scans. About 3,600 adults with at least one s…

Matched conditions: PCSK9

Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control

Last updated May 25, 2026 13:53 UTC

PCSK9

Get alerted when new PCSK9 trials appear

New drug combo aims to slash heart attacks in patients with dangerous plaques